Chimin(SH:603222) Sou Hu Cai Jing·2025-07-31 13:16Group 1 - The stock price of Jimin Health is reported at 6.92 yuan, down 0.15 yuan from the previous trading day, representing a decline of 2.12% [1] - The trading volume for the day was 89,780 hands, with a transaction amount of 0.63 million yuan [1] - Jimin Health operates in the pharmaceutical manufacturing industry, with its main business segments including pharmaceutical manufacturing, medical services, and pharmaceutical trade [1] Group 2 - According to the 2024 annual report, the pharmaceutical manufacturing business accounts for 55.95% of total revenue, while medical services contribute 41.43% [1] - As of July 31, the company has repurchased 2.01 million shares, representing 0.38% of the total share capital, with a repurchase amount of 12.09 million yuan [1] - In the first quarter of 2025, the company reported revenue of 181 million yuan, with a net profit loss of 13.64 million yuan [1] Group 3 - Data shows that on July 31, Jimin Health experienced a net outflow of main funds amounting to 16.57 million yuan, which is 0.46% of the circulating market value [1]